Literature DB >> 17081931

Polycystic ovary syndrome.

Joyce King1.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder, affecting between 4% and 8% of reproductive aged women. This syndrome, a complex disorder with multiple components, including reproductive, metabolic, and cardiovascular manifestations, has long-term health concerns that cross the life span. The diagnostic criteria for PCOS are ovarian dysfunction evidenced by oligomenorrhea or amenorrhea and clinical evidence of androgen excess (e.g., hirsutism and acne) in the absence of other conditions that can cause these same symptoms. This article reviews current knowledge about the pathophysiology, clinical manifestations, diagnosis, and management of this disorder.

Entities:  

Mesh:

Year:  2006        PMID: 17081931     DOI: 10.1016/j.jmwh.2006.01.008

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  10 in total

1.  Beneficial health effects of Menaquinone-7 on body composition, glycemic indices, lipid profile, and endocrine markers in polycystic ovary syndrome patients.

Authors:  Firoozeh Tarkesh; Bahia Namavar Jahromi; Najmeh Hejazi; Hamidreza Tabatabaee
Journal:  Food Sci Nutr       Date:  2020-09-04       Impact factor: 2.863

2.  The Effect of Flaxseed Supplementation on Hormonal Levels Associated with Polycystic Ovarian Syndrome: A Case Study.

Authors:  Debra A Nowak; Denise C Snyder; Ann J Brown; Wendy Demark-Wahnefried
Journal:  Curr Top Nutraceutical Res       Date:  2007       Impact factor: 0.416

3.  The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients.

Authors:  M Erdogan; M Karadeniz; A Berdeli; G Alper; O Caglayan; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

4.  Clinical, Biochemical, and Hormonal Associations in Female Patients with Acne: A Study and Literature Review.

Authors:  Sujata Mehta-Ambalal
Journal:  J Clin Aesthet Dermatol       Date:  2017-10-01

5.  Effect Of G2706A and G1051A polymorphisms of the ABCA1 gene on the lipid, oxidative stress and homocystein levels in Turkish patients with polycystıc ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdoğan; Zengi Ayhan; Murat Yalcin; Murat Olukman; Sevki Cetinkalp; Gulinnaz E Alper; Zuhal Eroglu; Asli Tetik; Vildan Cetintas; Ahmet G Ozgen; Fusun Saygili; Candeger Yilmaz
Journal:  Lipids Health Dis       Date:  2011-10-28       Impact factor: 3.876

6.  Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.

Authors:  Lan Li; Ji Eun Ryoo; Kyung-Ju Lee; Bum-Chae Choi; Kwang-Hyun Baek
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

7.  Letrozole as the first-line treatment of infertile women with poly cystic ovarian syndrome (PCOS) compared with clomiphene citrate: A clinical trial.

Authors:  Ataollah Ghahiri; Neda Mogharehabed; Mahboobeh Mamourian
Journal:  Adv Biomed Res       Date:  2016-01-29

Review 8.  Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review.

Authors:  Sri Chandana Tanguturi; Sreenivas Nagarakanti
Journal:  Indian J Endocrinol Metab       Date:  2018 Mar-Apr

9.  Correlation of Serum Homocysteine Levels and Hyperinsulinaemia with Body Mass Index in Polycystic Ovarian Syndrome.

Authors:  Rashmi Bhushan; Parul Sinha
Journal:  J Hum Reprod Sci       Date:  2022-03-31

10.  Divergences in Clinical, Anthropometric, Metabolic, and Hormonal Parameters among Different Phenotypes of Polycystic Ovary Syndrome Presenting at Endocrinology Outpatient Departments: A Multicenter Study from Bangladesh.

Authors:  A B M Kamrul-Hasan; Fatema Tuz Zahura Aalpona; Marufa Mustari; Farhana Akter; Mohammad Motiur Rahman; Shahjada Selim
Journal:  J Hum Reprod Sci       Date:  2020-12-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.